Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cian HealthcareBOM:542678 49 Gross Margin % is 28.56% as of Mar. 2026, which is 20% below its 10-year median of 35.78. GuruFocus rates BOM:542678 with a GF Score™ of 49/100 and a GF Value™ of ₹82.33 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 940 Drug Manufacturers companies, Cian Healthcare ranks worse than 90.64% on this metric.
Cian Healthcare Ltd gross margin has been in long-term decline. The average rate of decline per year is -13.6%.
The historical rank and industry rank for Cian Healthcare's Gross Margin % or its related term are showing as below:
BOM:542678'
s Gross Margin % Range Over the Past 10 Years
Min: 20.39 Med: 35.78 Max: 51.24
Current: 20.39
During the past 11 years, the highestGross Margin % of Cian Healthcare was 51.24%. The lowest was 20.39%. And the median was 35.78%.
BOM:542678's Gross Margin % is ranked worse than 90.64% of 940
companies
in the Drug Manufacturers industry
Industry Median: 48.35
vs BOM:542678: 20.39
Cian Healthcare had a gross margin of 28.56% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Cian Healthcare was -13.60% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Cian Healthcare had a gross margin of 28.56% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Cian Healthcare Gross Margin % Related Terms
Cian Healthcare Gross Margin % Historical Data
* Premium members only.
The historical data trend for Cian Healthcare's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542678 vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cian Healthcare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cian Healthcare Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cian Healthcare's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Cian Healthcare's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Cian Healthcare (BOM:542678) has a Gross Margin % of 28.56% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Cian Healthcare and its competitors. This is 20% below median its historical median of 35.78. Over the past decade, Cian Healthcare's Gross Margin % has ranged from 20.39 to 51.24. According to the industry distribution chart, Cian Healthcare ranks #852 out of 940 companies in the Drug Manufacturers industry, placing it in the top 90.6%.
Is Cian Healthcare's Gross Margin % too high?
Cian Healthcare's current Gross Margin % of 28.56% is 20% below median its 10-year median of 35.78. Over the past 10 years, this metric has ranged from a low of 20.39 to a high of 51.24. The Drug Manufacturers industry median Gross Margin % is 48.35. Cian Healthcare's value of 28.56% is 40.9% below this industry median. Based on the distribution chart, Cian Healthcare ranks #852 out of 940 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Cian Healthcare has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cian Healthcare's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cian Healthcare ranks #852 out of 940 companies for Gross Margin %. This places Cian Healthcare in the lower half of its industry. The industry median Gross Margin % is 48.35. Cian Healthcare's value of 28.56% is 40.9% below this benchmark. Historically, Cian Healthcare's own Gross Margin % has ranged from 20.39 to 51.24 over the past decade. While the company's 10-year median is 35.78 vs. the industry median of 48.35, Cian Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.35, based on 940 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cian Healthcare's current Gross Margin % of 28.56% is 40.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Cian Healthcare and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cian Healthcare's current Gross Margin % is 28.56%, which is 20% below median its own 10-year median of 35.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cian Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cian Healthcare (BOM:542678) is currently considered Possible Value Trap. The stock's GF Value™ is ₹82.33, compared to a current price of ₹9.55 — trading 88.4% below its estimated fair value. The current Gross Margin % is 28.56%, which is 20% below median its 10-year median of 35.78 and 40.9% below the Drug Manufacturers industry median of 48.35. Cian Healthcare's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Cian Healthcare (BOM:542678), the current Gross Margin % is 28.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cian Healthcare (BOM:542678) Overvalued in 2026?
Based on GuruFocus' analysis, Cian Healthcare stock appears to be undervalued.
The current stock price of ₹9.55 is trading 88.4% below its estimated GF Value™ of ₹82.33.
GuruFocus considers Cian Healthcare to be Possible Value Trap.
Key valuation signals for BOM:542678:
Gross Margin %: 28.56% (20% below median its 10-year median of 35.78)
GF Value™: ₹82.33 vs. price of ₹9.55 (88.4% below fair value)
Industry Position: 40.9% below the Drug Manufacturers median (#852 of 940)
No single metric tells the full story. See the BOM:542678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cian Healthcare Ltd is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company manufactures multiple product lines, including tablets, capsules, soft gels, liquid orals, ointments/creams and sachets, and cosmetics. Its portfolio comprises gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, vitamins, and nutrient products. The company operates in five sectors: Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party/Contract Manufacturing.
49GF Score
Get the complete analysis for BOM:542678
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542678 has been successfully added to your 
